Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Kyowa Hakko Kirin Pharma, Inc.
Sponsor:
Information provided by (Responsible Party):
Kyowa Hakko Kirin Pharma, Inc.
ClinicalTrials.gov Identifier:
NCT01728805
First received: October 25, 2012
Last updated: June 3, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)